Rejoinder: Estimating vaccine efficacy over time after a randomized study is unblinded.
Publication
, Journal Article
Tsiatis, AA; Davidian, M
Published in: Biometrics
September 2022
Duke Scholars
Published In
Biometrics
DOI
EISSN
1541-0420
Publication Date
September 2022
Volume
78
Issue
3
Start / End Page
848 / 851
Location
England
Related Subject Headings
- Vaccine Efficacy
- Statistics & Probability
- Randomized Controlled Trials as Topic
- 4905 Statistics
- 0199 Other Mathematical Sciences
- 0104 Statistics
Citation
APA
Chicago
ICMJE
MLA
NLM
Tsiatis, A. A., & Davidian, M. (2022). Rejoinder: Estimating vaccine efficacy over time after a randomized study is unblinded. Biometrics, 78(3), 848–851. https://doi.org/10.1111/biom.13539
Tsiatis, Anastasios A., and Marie Davidian. “Rejoinder: Estimating vaccine efficacy over time after a randomized study is unblinded.” Biometrics 78, no. 3 (September 2022): 848–51. https://doi.org/10.1111/biom.13539.
Tsiatis AA, Davidian M. Rejoinder: Estimating vaccine efficacy over time after a randomized study is unblinded. Biometrics. 2022 Sep;78(3):848–51.
Tsiatis, Anastasios A., and Marie Davidian. “Rejoinder: Estimating vaccine efficacy over time after a randomized study is unblinded.” Biometrics, vol. 78, no. 3, Sept. 2022, pp. 848–51. Pubmed, doi:10.1111/biom.13539.
Tsiatis AA, Davidian M. Rejoinder: Estimating vaccine efficacy over time after a randomized study is unblinded. Biometrics. 2022 Sep;78(3):848–851.
Published In
Biometrics
DOI
EISSN
1541-0420
Publication Date
September 2022
Volume
78
Issue
3
Start / End Page
848 / 851
Location
England
Related Subject Headings
- Vaccine Efficacy
- Statistics & Probability
- Randomized Controlled Trials as Topic
- 4905 Statistics
- 0199 Other Mathematical Sciences
- 0104 Statistics